Marrow Transplantation from Unrelated Donors
As bone marrow transplantation has evolved into the treatment of choice for many hematologic malignancies (Storb et al. 1984; Goldman et al. 1986; Thomas 1983), the lack of HLA-identical sibling donors for most patients has become a major issue. Given the current average family size in the USA of approximately 2.7 children, only 35% of patients can anticipate having an HLA-identical sibling (Nesbit et al. 1987; Appelbaum et al. 1986). For this reason, many centers have begun exploring the use of HLA-matched or HLA-similar unrelated volunteer donors.
KeywordsLymphoma Leukemia Anemia Oncol Methotrexate
Unable to display preview. Download preview PDF.
- Appelbaum FR, Hewlett J, Kopecky K, et al (1986) Prospective cooperative study of bone marrow transplantation versus continued chemotherapy for adult nonlymphocytic leukemia: a Southwest Oncology Group Study (Abstr). Blood 68:216aGoogle Scholar
- Beatty PG, Layrisse Z, van Seventer GA, et al (1989 a) T-cell recognition of HLA Class I determinants. In: Dupont B (ed) Immunogenetics and histocompatibility. Springer, Berlin Heidelberg New York, pp 359–362 (Immunobiology of HLA, vol 2)Google Scholar
- Foroozonfar N, Hobbs JR, Hugh-Jones K, et al (1977) Bone marrow transplant from an unrelated donor for chronic granulomatous disease. Lancet 1:210–213Google Scholar
- Goulmy E (1988) Minor histocompatibility antigens in man and their role in transplantation. In: Morris PJ, Tilney NL (eds) Transplant reviews. Saunders, Philadelphia, p 29Google Scholar
- McGlave PB (1990) Unrelated marrow transplants for CML. International Society for Experimental Hematology, Seattle, AugustGoogle Scholar
- Nesbit M, Buckley J, Lampkin B, et al (1987) Comparison of allogeneic bone marrow transplantation (BMT) with maintenance chemotherapy in previously untreated childhood acute non-lymphocytic leukemia (ANLL) (abstract). Proc Am Soc Clin Oncol 6:640aGoogle Scholar